DOCTAP LTD

Company Registration Number:
09518278 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

DOCTAP LTD

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

DOCTAP LTD

Balance sheet

As at 31 March 2025


Notes
2025
2024


£
£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 472,373 467,411
Investments:   0 0
Total fixed assets: 472,373 467,411
Current assets
Stocks: 16,696 0
Debtors:   2,480,392 2,299,704
Cash at bank and in hand: 70,902 414,777
Investments:   0 0
Total current assets: 2,567,990 2,714,481
Creditors: amounts falling due within one year:   (194,052) (302,000)
Net current assets (liabilities): 2,373,938 2,412,481
Total assets less current liabilities: 2,846,311 2,879,892
Creditors: amounts falling due after more than one year:   (10,174) (10,174)
Provision for liabilities: 0 0
Total net assets (liabilities): 2,836,137 2,869,718
Capital and reserves
Called up share capital: 324,260 324,260
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 2,511,877 2,545,458
Shareholders funds: 2,836,137 2,869,718

The notes form part of these financial statements

DOCTAP LTD

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 08 December 2025
and signed on behalf of the board by:

Name: Alexander Hamilton
Status: Director

The notes form part of these financial statements

DOCTAP LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

DOCTAP LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

2025 2024
Average number of employees during the period 24 27

DOCTAP LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Tangible Assets

Total
Cost £
At 01 April 2024 834,731
Additions 156,228
Disposals 0
Revaluations 0
Transfers 0
At 31 March 2025 990,959
Depreciation
At 01 April 2024 367,320
Charge for year 151,266
On disposals 0
Other adjustments 0
At 31 March 2025 518,586
Net book value
At 31 March 2025 472,373
At 31 March 2024 467,411

DOCTAP LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Financial commitments

The future minimum lease payments under non-cancellable operating leases falling due in less than one year total £237,604 (2024: £244,894) and within one to five years total £450,888 (2024: £688,493). All operating lease rental payments are charged to the profit and loss account when incurred